Eight years later, Zimmer Biomet FCPA case ends

Medical device maker Zimmer Biomet Holdings disclosed in a regulatory filing Wednesday that it has reached the end of its monitorship, eight years after resolving parallel settlements with the Department of Justice and Securities and Exchange Commission for violations of the Foreign Corrupt Practices Act (FCPA).